Q: Trump tariffs... impact on e commerce with non US countries. I see US analysts starting to reduce profit targets. I do hold the stock and I see 5i staff also hold the stock. What is your recommended course of action at this point... should I reduce my exposure? What would you do if you owned the stock? I do own GOOG and MSFT considering reducing my AMZN position and allocating it to MFST. Your thoughts would be appreciated. Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello
Any reason why electrovaya is surging? A week ago Trump commented on possible reclassification if cannibis. However stocks like canopy are going up and down daily. Is it worth putting some money to work? Thank you
Any reason why electrovaya is surging? A week ago Trump commented on possible reclassification if cannibis. However stocks like canopy are going up and down daily. Is it worth putting some money to work? Thank you
Q: It was announced today that Trump fired a Federal Reserve governor (Lisa Cook). Jerome Powell's term will end in May 2026. It seems Trump is really pushing for lower interest rates, and my question are::
1) If bond investors start to lose faith that the Fed will be able to control inflation, can the Fed still lower rates?
2) If inflation starts to take off again, is it better to be in stocks? If so, what sectors should people hide in?
3) Would you make any big changes to portfolio weightings or cash positions at this time?
1) If bond investors start to lose faith that the Fed will be able to control inflation, can the Fed still lower rates?
2) If inflation starts to take off again, is it better to be in stocks? If so, what sectors should people hide in?
3) Would you make any big changes to portfolio weightings or cash positions at this time?
Q: Hello everyone,
Mckesson (MCK) has recently pulled back and just upped it's dividend. I wanted your thoughts on the name and whether it's a good time to buy, in light of the challenges in the sector from Trump's health care reform focus.
Thanks again.
Peter
Mckesson (MCK) has recently pulled back and just upped it's dividend. I wanted your thoughts on the name and whether it's a good time to buy, in light of the challenges in the sector from Trump's health care reform focus.
Thanks again.
Peter
-
iShares Core Canadian Universe Bond Index ETF (XBB $28.31)
-
iShares Core Canadian Long Term Bond Index ETF (XLB $18.79)
-
iShares U.S. High Yield Bond Index ETF (CAD-Hedged) (XHY $16.79)
-
PIMCO Active Bond ETF (BOND $93.55)
Q: Good morning - With the market rising so nicely, it's timely for me to do some re-balancing. For fixed income, I have positions I xlb, xbb and XHY. What fixed income investments do you suggest these days. I could add to the above and/or to corporate bonds, if that makes sense. But, I am nervous about the prospects for Canadian companies as the Trump tariffs take their toll. What does your crystal ball reveal? Many thanks.
Q: I think Trump is headed down the wrong road with his goal to isolate the American economy from the rest of the world and bring back manufacturing to the United States.
I believe that globalization is the better economic system. This leads me to my question: Can you please provide me with a list of your top 10 Canadian companies that have developed their companies into successful, profitable, global operations and have the most possibility of continuing that success?
If you could list them in order of most profitable to least it would be most helpful.
I believe that globalization is the better economic system. This leads me to my question: Can you please provide me with a list of your top 10 Canadian companies that have developed their companies into successful, profitable, global operations and have the most possibility of continuing that success?
If you could list them in order of most profitable to least it would be most helpful.
-
UnitedHealth Group Incorporated (DE) (UNH $331.02)
-
Lithium Americas Corp. (LAC $8.30)
-
Harvest Healthcare Leaders Income ETF (HHL $7.76)
-
CRISPR Therapeutics AG (CRSP $53.51)
-
Sigma Lithium Corporation (SGML $17.21)
Q: There are two questions here, the first relates to the abandonment of science, a policy issue. I note that HHL has recovered significantly and reportedly follows the prospects of leaders in medical science, in which Crisper also participates, that issue is now lagging and down. While this appears to be an extraordinarily cruel hit to an essential industry, question I have - is there a reason which might be ordinarily attributed to each of these related issues, and how do you perceive the outcome?
The second question relates to the price of Lithium. It is my understanding that China has closed a major supplier of Lithium and that this briefly sent the price soaring. It is my guess that this has occurred because salt has replaced Lithium as an energy storage mechanism for major - grid related - energy storage facilities, despite its lower energy density and because of its availability and cost to produce, but that Lithium is expected to be used in cars, bikes, and hand held devices because of its higher energy density/ capacity. Does this coincide with your view of the lithium industry's prospects and do you have an opinion for the trajectory for the price of Lithium?
The second question relates to the price of Lithium. It is my understanding that China has closed a major supplier of Lithium and that this briefly sent the price soaring. It is my guess that this has occurred because salt has replaced Lithium as an energy storage mechanism for major - grid related - energy storage facilities, despite its lower energy density and because of its availability and cost to produce, but that Lithium is expected to be used in cars, bikes, and hand held devices because of its higher energy density/ capacity. Does this coincide with your view of the lithium industry's prospects and do you have an opinion for the trajectory for the price of Lithium?
Q: Could you please provide your analysis of GE Vernova.
We have been interested in the Co, for exposure to Power Infrastructure sector/Nuclear. However, stock has continued to march to new highs, except for past 2 weeks, following a general weakness in most momentum names.
Do you like the Company and would you be comfortable buying at current levels, say $600. after the pull back ? ( More so, stock exhibiting a little bit of support around $585-$595, in Wednesday's trading ).
Thank You
We have been interested in the Co, for exposure to Power Infrastructure sector/Nuclear. However, stock has continued to march to new highs, except for past 2 weeks, following a general weakness in most momentum names.
Do you like the Company and would you be comfortable buying at current levels, say $600. after the pull back ? ( More so, stock exhibiting a little bit of support around $585-$595, in Wednesday's trading ).
Thank You
-
Eli Lilly and Company (LLY $1,038.40)
-
UnitedHealth Group Incorporated (DE) (UNH $331.02)
-
Harvest Healthcare Leaders Income ETF (HHL $7.76)
-
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $9.37)
Q: I hold HHL in my RRIF which is primarily focused on income. I am considering switching HHL to
HHLE. This would increase my income by approximately 30% on this money and allow me to keep the same list of healthcare stocks. Does this make sense; any downsides ; am I missing anything?
As an aside , I am at breakeven with HHL as the sector is under pressure from Trump and also United Healthcare has dampened the sector. But with Trump wanting lower drug prices , the companies will be going overseas to compensate for lower US revenue as witnessed by Eli Lilly raising international prices for Mounjaro.
Thanks .Derek
HHLE. This would increase my income by approximately 30% on this money and allow me to keep the same list of healthcare stocks. Does this make sense; any downsides ; am I missing anything?
As an aside , I am at breakeven with HHL as the sector is under pressure from Trump and also United Healthcare has dampened the sector. But with Trump wanting lower drug prices , the companies will be going overseas to compensate for lower US revenue as witnessed by Eli Lilly raising international prices for Mounjaro.
Thanks .Derek
Q: In January you noted:
We are mixed here. We don't like the leverage and the sector may still be weak under Trump policies (solar).
What's changed since then that made you come around to it and add it to your growth portfolio in July?
We are mixed here. We don't like the leverage and the sector may still be weak under Trump policies (solar).
What's changed since then that made you come around to it and add it to your growth portfolio in July?
Q: hi folks:
did well with this company in the past
i see it has sold off quite hard; it did get a big trump bump
can you pls provide an update? and would you consider it worthwhile at this point
thanks in advance
did well with this company in the past
i see it has sold off quite hard; it did get a big trump bump
can you pls provide an update? and would you consider it worthwhile at this point
thanks in advance
Q: at todays prices and looking forward for dividends and growth which stock would you buy today , bip.un or ppl or none. do you think we are overbought in this market [tsx and dow] and will have a pullback come fall?
Q: Like most people, I am worried about Trump tampering with the fed. That being said, I noticed in a recent article, that the people Trump has in mind for Powell's post tend to look more at forecasting rather than recent data. How much of this is spin and how much is forecasting a legitimate approach for the fed?
Q: Hello! Thank you for all your amazing information. I hold some physical ounces of gold in my portfolio as a hedge. What do you think Trump's threat of a tariff on gold by the end of the month will have on the price per ounce? I am thinking of selling it and replacing it with a gold ETF when the (gold) dust settles.
Q: Hi,
I'm looking at a clip from the Kobeissi Letter which reads as follows:
BREAKING: Nvidia, $NVDA, and AMD, $AMD, have reportedly agreed to give the US government 15% of their revenues from chip sales in China.
This is being described as an "unusual agreement" with Trump in order to obtain export licenses for the chips.
2025-08-10, 1:56 PM
Having done some quick math, I am thinking this could amount to as much as 2.5 billion based on the value they sold to China last year. If that's correct, then is it possible 2.5 billion amounts to just over 4% of 2024 revenue for NVDA?
These seem like very large numbers to me, but I have to ask whether or not you feel this could be material to NVDA or not?
Of course this tidbit happened to be published on Sunday afternoon, which seems to be the usual time Trump decides to find yet another monkey wrench to hurl at the US economy. I also wonder about the 'unusual arrangement' comment, as that same thing was mentioned in the deal that allowed Japan to purchase US Steel, was it not?
Any thoughts you have to offer would be most welcome.
Thanks!
I'm looking at a clip from the Kobeissi Letter which reads as follows:
BREAKING: Nvidia, $NVDA, and AMD, $AMD, have reportedly agreed to give the US government 15% of their revenues from chip sales in China.
This is being described as an "unusual agreement" with Trump in order to obtain export licenses for the chips.
2025-08-10, 1:56 PM
Having done some quick math, I am thinking this could amount to as much as 2.5 billion based on the value they sold to China last year. If that's correct, then is it possible 2.5 billion amounts to just over 4% of 2024 revenue for NVDA?
These seem like very large numbers to me, but I have to ask whether or not you feel this could be material to NVDA or not?
Of course this tidbit happened to be published on Sunday afternoon, which seems to be the usual time Trump decides to find yet another monkey wrench to hurl at the US economy. I also wonder about the 'unusual arrangement' comment, as that same thing was mentioned in the deal that allowed Japan to purchase US Steel, was it not?
Any thoughts you have to offer would be most welcome.
Thanks!
Q: I hold LLY shares. Following the announcement of weight loss trial results, the stock declined approximately 14%, despite an improved 2025 outlook after a positive Q2 report. My current position is down 20%, and this investment makes up 5% of my portfolio.
Is this an appropriate time to consider increasing my position? Alternatively, are there other securities that you would prefer ? I would like to take advantage of the Trump turmoil. I am overweight technology.
Thank you kindly. Very appreciative of your comments.
Elaine
Is this an appropriate time to consider increasing my position? Alternatively, are there other securities that you would prefer ? I would like to take advantage of the Trump turmoil. I am overweight technology.
Thank you kindly. Very appreciative of your comments.
Elaine
Q: Can you please explain the press releases by $oscr $cnc and others related to Medicare and the weak skate prices for these Healthcare companies? Is this weakness likely to last with the Trump policy changes? It's there value here or a longer lasting fundamental change to the revenue potential?
Q: I've held FCX for a few years now, and it hasn't really gone anywhere. Would it make sense to sell it and buy AEM?
Thank you for all that you do.
Thank you for all that you do.
Q: Hi Would you initiate a new position in Nvidia now? This would be for a hold for a minimum of three years. thanks.
Q: Hi 5i, Any news regarding today's pop in Apple? Thx.